Service

Starting out from your targets or your molecules, we design and select the best drug candidates

IDDS (Integrated Drug Discovery Services) Proof of concept - Pharmacology DMPK Bioanalysis Biobanking Translational Biomarkers Biodecontamination / biosafety

Partnership

Use our development programs at a very early stage by entering into a long-term strategic partnership

Kinase inhibitor development programs Technology Partnership

Licensing

License technologies, drug candidates and radiotracers from Oncodesign’s portfolio

Kinase inhibitors in oncology, CNS and inflammation Technologies

Technologies

Nanocyclix®
T.O.T®
PREDICT®
Chi-mice®
Pharmimage®
Oncosnipe®

Oncodesign News

November 15, 2017

  • Activin receptor-like kinase 1 (ALK1) is a target involved in angiogenesis with promising applications in cancer
...

October 18, 2017

  • A structural competitiveness project (PSPC) under the “Investments for the Future Programme” coordinated by
...

Word from the Chairman

Since our April 2014 IPO, we have accelerated our development and have become an international biopharma company specialized in precision medicine pursuing ambitious development objectives underpinned by acquisition-led growth and investments in innovative therapeutic research programs.

Learn More

Careers

Oncodesign’s mission is to discover innovative new therapies effective against cancer and serious illnesses with unmet medical needs.

Oncodesign has opted to take the time to build up all the dimensions of its organization—scientific, technical, business, starting with the most crucial one, the human dimension.

Our values Job offers/work-study arrangements Internship available Spontaneous applications

Contact Us

Sales team

If you have any questions, please contact the member of our sales team responsible for your geographical region, and we will get back to you as swiftly as we can.

Connect with us now